4-Bromobenzo[b]thiophene CAS 5118-13-8 Kuchena >97.0% (GC) Brexpiprazole Yepakati Mugadziri Wemifananidzo

4-Bromobenzo[b]thiophene CAS 5118-13-8 Kuchena >97.0% (GC) Brexpiprazole Intermediate Manufacturer

Tsanangudzo Pfupi:

Kemikari Zita: 4-Bromobenzo[b]thiophene

CAS: 5118-13-8

Kuchena: > 97.0% (GC)

Chitarisiko: Chiedza Yellow Solid Powder

Pakati peBrexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-imwe CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Chemical Properties:

Chemical Name	4-Bromobenzo[b]thiophene
Mashoko anoreva zvakafanana	4-Bromobenzothiophene;4-Bromo-Benzo[b]thiophene;4-Bromo-1-Benzothiophene
Nhamba yeCAS	5118-13-8
Nhamba yeCAT	RF-PI1103
Stock Status	MuStock, Kugona 30MT/Gore
Molecular Formula	C8H5BrS
Molecular Weight	213.09
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	Chiedza Yellow Solid Powder
Kuchena / Analysis Method	>97.0% (GC)
Infrared Spectrum	Inopindirana neChimiro
NMR	Inopindirana neChimiro
Test Standard	Enterprise Standard
Usage	Pakati peBrexpiprazole (CAS: 913611-97-9)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

FAQ:

Application:

4-Bromobenzo [b] thiophene (CAS: 5118-13-8) inoshandiswa sechinhu chinobatsira chekugadzira chepakati, uye chinonyanya kutumirwa kuIndia, North America, Korea, Japanese, uye Europe.4-Bromobenzo [b] thiophene iri pakati peBrexpiprazole (CAS: 913611-97-9).Brexpiprazole yakatenderwa neUS Food and Drug Administration (FDA) musi waChikunguru 10, 2015, pakurapa schizophrenia, uye senzira yekuwedzera yekuora mwoyo.Brexpiprazole yakagadzirirwa kupa hunyanzvi hwekuita uye kushivirira (semuenzaniso, kushomeka akathisia, kusagadzikana uye / kana kushaya hope) pamusoro peakagadziriswa adjunctive kurapa kwekuora mwoyo kukuru (MDD).Brexpiprazole, inotengeswa pasi pezita rechiratidzo Rexulti pakati pevamwe, ndeye atypical antipsychotic.Brexpiprazole is dopamine D2 receptor partial agonist uye yakatsanangurwa se "serotonin-dopamine chiitiko modulator" (SDAM).Brexpiprazole yakagadzirwa naOtsuka naLundbeck, uye inoonekwa semutsivi weOtsuka's top-selling atypical antipsychotic aripiprazole (Abilify).